Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 29, 2023
Product Development

Aug. 29 Quick Takes: Phase III miss in DMD for FibroGen

Plus: Expanded label for BMS’s Reblozyl, Apellis restructuring and updates from Inhibrx, CEPI, iCamuno, Regeneron, Nevia  
BioCentury | Jul 1, 2021
Finance

June 30 Quick Takes: Beam looks to complement Apellis; plus Intellia, Aerovate, Hutchmed, Spero-Pfizer and more

Beam Therapeutics Inc. (NASDAQ:BEAM) unveiled a five-year partnership with Apellis Pharmaceuticals Inc. (NASDAQ:APLS) to collaborate on up to six research programs against complement system targets,
BioCentury | Jun 5, 2021
Targets & Mechanisms

Going beyond genetic medicines for muscular dystrophy

Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones
BioCentury | Jun 11, 2020
Product Development

J&J picks up pace for Warp Speed COVID-19 vaccine

Corning to produce glass packaging for countermeasures; plus progress on host-targeted therapies
BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

Aluda begins to unveil pipeline, starting with first-in-class anti-VIM program for fibrosis
BioCentury | Aug 26, 2019
Company News

FibroGen’s Neff passes away

BioCentury | Jul 20, 2018
Financial News

RNAi company OliX lists in Korea

Items per page:
1 - 10 of 105